Reduced-intensity conditioning and blood stem cell transplantation from an HLA-identical sibling for severe aplastic anaemia: two patients with successful engraftment but a fatal post-transplant lymphoproliferative disorder in the other.
Itälä
Maija
M
Department of Medicine, Turku University Central Hospital, PL 52, Turku, 20521 Finland. maija.itala@tyks.fi
Aho
Heikki
H
Remes
Kari
K
D000305:Adrenal Cortex Hormones / Q000009:adverse effects / Q000627:therapeutic use; D000741:Anemia, Aplastic / Q000150:complications / Q000188:drug therapy / Q000628:therapy*; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D016572:Cyclosporine / Q000627:therapeutic use; D003924:Diabetes Mellitus, Type 2 / Q000150:complications; D004351:Drug Resistance; D020031:Epstein-Barr Virus Infections / Q000150:complications; D017809:Fatal Outcome; D006648:Histocompatibility; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016393:Lymphoma, B-Cell / Q000209:etiology* / Q000821:virology; D008297:Male; D008875:Middle Aged; D036102:Peripheral Blood Stem Cell Transplantation / Q000009:adverse effects; D011241:Prednisone / Q000627:therapeutic use; D035781:Siblings; D013601:T-Lymphocytes; D019172:Transplantation Conditioning / Q000379:methods*; D014184:Transplantation, Homologous; D016896:Treatment Outcome; D014412:Tumor Virus Infections / Q000150:complications
D000305:Adrenal Cortex Hormones; D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D011241:Prednisone